Search
Filter Results
Displaying 61–70 of 865 results for “vision connection”
-
Jun 24, 2016
A Steady Hand in Saving Vision
Research NewsSubretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
-
Oct 8, 2015
A Leap Forward: Spark Therapeutics Seeks FDA Approval for its Vision-Restoring Gene Therapy
Research NewsA Leap Forward: Spark Therapeutics Seeks FDA Approval for its Vision-Restoring Gene Therapy
-
Jan 22, 2014
Choroideremia Gene Therapy Improves Vision in Human Study
Research NewsResearchers were able to improve vision in five of six people with choroideremia participating in a clinical trial.
-
Mar 15, 2013
Proving a Vision-Saving Treatment Works
Research NewsThe information gleaned from ProgSTAR will be of enormous value in designing future clinical trials for Stargardt disease treatments.
-
Sep 30, 2025
Research NewsDurable vision improvements were also observed out to 18 months for previously dosed adult patients in the trial.
-
VISIONS 2026: United in Vision Schedule
The United in Vision 2026 conference unites two prestigious events—the Foundation Fighting Blindness VISIONS conference and the Retina International World Congress—into one extraordinary global gathering. Scheduled from Wednesday, June 10 to Saturday, June 13, 2026, at the Fort Worth Convention Center in Fort Worth, Texas,
-
Feb 24, 2025
LCA4 Gene Therapy Restores Meaningful Vision for Blind Children
Research NewsMeiraGTx hopes to apply for marketing approval in the UK for the gene therapy.
-
May 20, 2024
WellnessIsaiah Bingham is the first legally blind football player in Delaware. At just 14 years old, he’s excelling as a team captain and award-winning athlete and is inspiring others as he advocates for those with disabilities.
-
Mar 26, 2024
Opus Reports Vision Improvements for Patients in LCA5 Gene Therapy Clinical Trial
Research NewsThe company plans to administer a higher dose of the emerging gene therapy to the next group of patients.
-
Mar 30, 2023
Research NewsMost participants with advanced retinitis pigmentosa (RP) in the trial had improved navigation and/or object discrimination in reduced lighting conditions